TiumBio Co., Ltd. (KOSDAQ:321550)

TiumBio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16,454	10,509	18,130	6,880	3,463
Short-Term Investments	-0	3,000	-	33,755	40,000
Trading Asset Securities	34,170	26,948	16,970	-	25,113
Cash & Short-Term Investments	50,624	40,457	35,100	40,635	68,576
Cash Growth	25.13%	15.26%	-13.62%	-40.74%	-22.85%
Accounts Receivable	743.01	537.39	90.8	23.44	544
Other Receivables	526.39	633.93	369.93	943.81	164.5
Receivables	1,318	1,171	460.73	967.24	708.5
Inventory	356.06	-	-	-	-
Prepaid Expenses	94.98	201.24	182.85	136.88	157.83
Other Current Assets	6,520	3,481	4,551	161.96	409.06
Total Current Assets	58,914	45,311	40,295	41,901	69,851
Property, Plant & Equipment	44,721	42,031	24,362	14,826	2,682
Long-Term Investments	899.99	23,311	24,579	46,094	10,411
Goodwill	1,326	-	-	-	-
Other Intangible Assets	423.44	584.69	1,072	1,324	1,705
Other Long-Term Assets	1,014	8,309	5,951	12,591	702.51
Total Assets	107,298	119,546	96,259	116,735	85,351
Accounts Payable	68.65	-	-	-	-
Accrued Expenses	2,999	2,461	1,970	2,537	1,339
Short-Term Debt	12,967	4,869	19,133	-	-
Current Portion of Leases	532.26	895.1	516.79	850.28	317.93
Current Unearned Revenue	76.2	316.11	43.65	25.15	4.15
Other Current Liabilities	10,818	4,499	8,446	1,054	115.67
Total Current Liabilities	27,461	13,041	30,110	4,467	1,777
Long-Term Debt	16,400	22,655	2,708	17,787	-
Long-Term Leases	280.16	580.61	853.14	836.94	931.16
Long-Term Unearned Revenue	48.87	86.12	130.53	140.29	73.84
Long-Term Deferred Tax Liabilities	326.34	-	-	-	-
Other Long-Term Liabilities	143.33	2,031	170.87	3,185	63.16
Total Liabilities	44,659	38,393	33,972	26,416	2,845
Common Stock	13,356	12,475	12,009	11,959	11,892
Additional Paid-In Capital	169,920	169,084	145,553	144,535	110,895
Retained Earnings	-141,848	-121,204	-103,293	-73,413	-41,776
Comprehensive Income & Other	9,715	8,168	6,090	3,804	1,495
Total Common Equity	51,143	68,522	60,359	86,884	82,507
Minority Interest	-1,713	296.33	1,249	2,746	-
Shareholders' Equity	62,639	81,153	62,287	90,319	82,507
Total Liabilities & Equity	107,298	119,546	96,259	116,735	85,351
Total Debt	30,180	29,000	23,211	19,474	1,249
Net Cash (Debt)	20,444	11,457	11,889	21,161	67,327
Net Cash Growth	78.44%	-3.63%	-43.82%	-68.57%	-24.15%
Net Cash Per Share	791.29	469.53	496.13	888.58	2866.51
Filing Date Shares Outstanding	26.71	24.95	24.02	23.92	23.78
Total Common Shares Outstanding	26.71	24.95	24.02	23.92	23.78
Working Capital	31,453	32,270	10,185	37,434	68,075
Book Value Per Share	1914.60	2746.48	2513.07	3632.69	3469.01
Tangible Book Value	49,394	67,938	59,287	85,560	80,802
Tangible Book Value Per Share	1849.11	2723.05	2468.43	3577.35	3397.32
Land	14,856	12,783	-	-	-
Buildings	19,041	17,510	-	-	-
Machinery	15,794	14,161	11,469	8,196	1,792
Construction In Progress	44.8	-	14,275	5,415	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.